Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) can be caused by mutations in the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4 and CHRNB2. 19383498 2009
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor. 18534914 2008
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Mutation analysis of the CHRNB2 gene revealed a c.859G>A transition (Val287Met) within the second transmembrane domain, identical to that previously described in a Scottish ADNFLE family. 17900292 2008
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GermlineCausalMutation disease ORPHANET The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. 11062464 2000
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE In order to assess the genetic defects in NFLE, we performed a mutation screening in 33 unrelated patients with sporadic NFLE by amplifying and sequencing bidirectionally TM 1-3 of CHRNA4, CHRNB2 and CHRNA2 which contain the mutations reported in ADNFLE. 19058950 2009
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE To investigate this issue of phenotypic heterogeneity, we prospectively carried out a high-resolution 3-T magnetic resonance imaging (MRI) study in an ADNFLE family containing 10 affected members including one pharmacoresistant patient and carrying the V287L mutation of the CHRN beta2 subunit (CHRNB2). 22897520 2013
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE ADNFLE has been associated with mutations in two genes coding for the nicotinic acetylcholine receptor (CHRNA4 and CHRNB2). 12782965 2003
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is known to be caused by mutations in the transmembrane regions of the neuronal nicotinic acetylcholine receptor (nAChR) genes CHRNA4 and CHRNB2. 17602836 2007
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE A case of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) coexisting with pervasive developmental disorder harboring SCN1A mutation in addition to CHRNB2 mutation. 23032131 2012
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a rare familial seizure disorder caused by mutations in at least two different subunit genes of the neuronal nicotinic acetylcholine receptor (nAChR), CHRNA4 and CHRNB2. 22036597 2012
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE However, ADNFLE is genetically heterogeneous and mutations in CHRNA4 and CHRNB2 account for only a minority of ADNFLE cases. 12195439 2002
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is partly caused by mutations in the nicotinic acetylcholine receptor (nAChR) genes CHRNA4, CHRNB2, and CHRNA2. 21497487 2011
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 CausalMutation disease CLINVAR
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 Biomarker disease BEFREE Although over hundred families are on record, only a minority of them have been linked to mutations in the genes coding for the alpha4, alpha2 and beta2 (CHRNA4, CHRNA2, and CHRNB2) subunits of the nAChRs, indicating that ADNFLE is genetically heterogeneous despite a relatively homogeneous clinical picture. 17662253 2007
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 Biomarker disease BEFREE Certain mutations in specific parts of the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4, CHRNB2, and probably CHRNA2, can cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). 18456869 2008
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE These data, obtained in the largest ADNFLE cohort so far analyzed, demonstrate the rarity of the identified CHRNB2 mutations in ADNFLE patients. 11952766 2002
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
0.500 GeneticVariation disease BEFREE Mutations responsible for autosomal dominant nocturnal frontal lobe epilepsy have been identified in two members of the neuronal nicotinic acetylcholine receptor gene family: CHRNA4(ENFL1 locus) and CHRNB2 (ENFL3 locus) coding for alpha4 and beta2 subunit, respectively. 15245761 2004
CUI: C0751468
Disease: Bulbocavernosus Reflex, Decreased
Bulbocavernosus Reflex, Decreased
0.300 Therapeutic phenotype CTD_human The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse. 23419392 2013
CUI: C0751469
Disease: Bulbocavernousus Reflex Absent
Bulbocavernousus Reflex Absent
0.300 Therapeutic phenotype CTD_human The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse. 23419392 2013
CUI: C0431375
Disease: Classical Lissencephaly
Classical Lissencephaly
0.010 Biomarker disease BEFREE Specifically, downregulation of the nicotinic cholinergic receptor subunit β-2 gene (CHRNB2), monoaminergic enzymes catechol-O-methyltransferase (COMT) and dopa decarboxylase (DDC), chloride channels CLCN4 and CLCN5, scaffolding protein caveolin 1 (CAV1), cortical development/cytoskeleton element lissencephaly 1 (LIS1), and intracellular signaling cascade member adenylate cyclase 3 (ADCY3) was observed in pS422-immunreactive nbM neurons in CTE patients. 29338612 2018
CUI: C0497327
Disease: Dementia
Dementia
0.010 Biomarker disease LHGDN Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. 16023355 2006
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.010 Biomarker phenotype BEFREE Since both nicotine dependence (ND) and depressive phenotype are complex disorders, we investigated the effects of a significant early life experience, maternal bonding style (MB) and CHRNB2 gene SNPs on smoking-related depression. 25640319 2015
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.010 Biomarker disease BEFREE Since both nicotine dependence (ND) and depressive phenotype are complex disorders, we investigated the effects of a significant early life experience, maternal bonding style (MB) and CHRNB2 gene SNPs on smoking-related depression. 25640319 2015
CUI: C0012833
Disease: Dizziness
Dizziness
0.010 Biomarker phenotype BEFREE Individuals with the minor allele of CHRNB2 variants experienced less nausea than did those without the minor allele, consistent with previously reported findings for CHRNB2 and the occurrence of nausea and dizziness as a consequence of first smoking attempt in adolescents, and with the known neurophysiology of nausea. 21606948 2012
CUI: C0013080
Disease: Down Syndrome
Down Syndrome
0.010 AlteredExpression disease LHGDN Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease. 11771745 2001